BearmanS.I.: The syndrome of hepatic veno-occlusive disease after marrow transplantation.Blood, 85: 3005–3020, 1995.
2.
McDonaldG.B.HindsM.S.FisherL.D.SchochH.G.WolfordJ.L.BanajiM.HardinB.J.ShulmanH.M.CliftR.A.: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation - A cohort study of 355 patients.Ann Int Med, 118: 255–267, 1993.
3.
JonesR.J.LeeK.S.K.BeschornerW.E.VogelV.G.GrowchowL.B.VogelsangG.B.SensenbrennerL.L.SantosG.W.SaraiR.: Veno-occlusive disease of the liver following bone marrow transplantation.Transplantation, 44: 778–783, 1987.
4.
LeeJ.L.GooleyT.BensingerW.SchiffmanK.McDonaldG.B.: Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.Biology of Blood & Marrow Transplant, 5: 306–315, 1999.
5.
BearmanS.I.LeeJ.L.BarónA.E.McDonaldG.B.: Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients.Blood, 89: 1501–1506, 1997.
6.
KulkamiS.RodriguezM.LafuenteA.MateosP.MehtaJ.SinghalS.SasoR.TaitD.TreleavenJ.G. and PowlesR.L.: Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD).Bone Marrow Transplant, 23: 803–807, 1999.
ShulmanH.M.FisherL.B.SchochH.G.HenneK.W.McDonaldG.B.: Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.Hepatology, 19: 1171–1180, 1994.
9.
AllenJ.R.CarstensL.A.KatagiriG.J.: Hepatic veins of monkeys with veno-occlusive disease. Sequential ultrastructural changes.Arch Path, 87: 279–289, 1969.
10.
DeLeveL.D.McCuskeyR.S.WangX.HuL.McCuskeyM.K.EpsteinR.B.KanelG.: Characterization of a reproducible rat model of hepatic veno-occlusive disease.Hepatology, 29: 1779–1791, 1999.
11.
DeLeveL.D.: Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.Hepatology, 24: 830–837, 1996.
12.
DeLeveL.D.: Dacarbazine toxicity in murine liver cells: a novel model of hepatic endothelial injury and glutathione defense.J Pharmacol Exp Ther, 268: 1261–1270, 1994.
13.
DeLeveL.D.WangX.KuhlenkampJ.F.KaplowitzN.: Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venooclusive disease.Hepatology, 23: 589–599, 1996.
DeLeveL.D.WangX.: Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes.Pharmacology, 60: 143–154, 2000.
16.
HemminkiK.KallamaS.FalckK.: Correlations of alkylating activity and mutagenicity in bacteria of cytostatic drugs.Acta Pharmacol Toxicol, 53: 421–428, 1983.
17.
MillarB.C.TilbyM.J.OrmerodM.G.PayneA.W.JinksS.LoverockP.S.: Comparative studies of total cross-linking, cell survival and cell cycle perturbations in Chinese hamster cells treated with alkylating agents in vitro.Biochem Pharmacol, 35: 1163–1169, 1986.
18.
OhtaY.KohdaK.KimotoH.OkanoT.KawazoeY.: Cytotoxicity of fluorine-containing alkyl alkanesulfonates to cultured leukemia L1210 cells.Chem Pharm Bull, 36: 2410–2416, 1988.
19.
PuriE.C.BaumeisterM.FautzR.HechenbergerC.M.HertnerT.MeliC.MiltenburgerH.G.SchmidB.SchweglerR.SeebergA.M.: Inter-laboratory ring trial of in vitro DNA repair tests using rat hepatocytes: further testing and conclusive remarks.Mutagenesis, 6: 471–478, 1991.
20.
MéresseV.HartmannO.VassalG.BenhamouE.Valteau-CouanetD.BrugieresL.LemerleJ.: Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.Bone Marrow Transplant, 10: 135–141, 1992.
21.
BrasG.JeliffeD.B.StuartK.L.: Veno-occlusive disease of the liver with non-portal type of cirrhosis occurring in Jamaica.Arch Path, 57: 285–300, 1954.
22.
ChauvinP.DillonJ.C.MorenA.: An outbreak of Heliotrope food poisoning, Tadjikistan, November 1992-March 1993.Santé, 4: 263–268, 1994.
23.
SelzerG.ParkerR.G.F.: Senecio poisoning exhibiting as Chiari's syndrome: a report on twelve cases.Am J Pathol, 27: 885–907, 1950.
24.
WillmotF.C.RobertsonG.W.: Senecio disease, or cirrhosis of the liver due to senecio poisoning.Lancet, 2: 848–849, 1920.
25.
WangX.KanelG.C.DeLeveL.D.: Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat.Hepatology, 31: 428–434, 2000.
26.
RingdénO.RembergerM.LehmannS.HentschkeP.MattsonJ.KlaessonS.AschanJ.: N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.Bone Marrow Transplant, 25: 993–996, 2000.
